Nuclear Medicine and Molecular Imaging in Cancer Diagnosis, Therapy, and Treatment Assessment
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 30 October 2025 | Viewed by 142
Special Issue Editor
Interests: medical imaging; molecular imaging; PET/CT; theranostics; cancer imaging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nuclear medicine and molecular imaging have transformed cancer management by providing unparalleled insights into tumor biology. These modalities are integral not only for early detection and precise staging but also for guiding targeted therapy, monitoring disease progression, predicting prognosis, and assessing minimal residual disease. The integration of advanced imaging technologies such as PET, SPECT, PET/CT, and PET/MRI, along with novel radiopharmaceuticals and theranostic agents, has significantly improved diagnostic accuracy and personalized treatment strategies. Furthermore, innovations in artificial intelligence, radiomics, quantitative imaging biomarkers, and multi-parametric imaging are enhancing precision in oncologic decision-making. This Special Issue invites contributions on a broad spectrum of topics, including novel radiotracers, AI-driven image analysis, multi-modal imaging applications, and the evolving role of nuclear medicine in precision oncology. We welcome original research, reviews, and clinical studies that contribute to the advancement of molecular imaging in cancer diagnosis, treatment planning, and therapeutic assessment.
Dr. Sara Harsini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nuclear medicine
- molecular imaging
- PET/CT
- theranostics
- cancer diagnosis
- treatment monitoring
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
